Zusammenfassung
Das Fibromyalgiesyndrom (FMS) und das myofasziale Schmerzsyndrom („myofascial pain syndrome“, MPS) sind die bekanntesten Vertreter der Gruppe der chronischen nichtentzündlichen Schmerzen im Bereich der Muskulatur und Sehnenübergänge. Wichtige Kriterien in der Diagnose dieser Erkrankungen sind dabei die „tender points“ und die „trigger points“. Während Tender points, entsprechend den ACR-Kriterien, unbedingt für die Diagnose eines FMS notwendig sind, sind die Trigger points das typische Zeichen des MPS.
Ein wesentlicher Unterschied besteht darin, dass Tender points bisher nur durch ihre Lokalisation definiert werden konnten, während Trigger points durch Palpation ertastet werden können und auf Reizung mit einer lokalisierten Schmerzreaktion antworten können. Weiter zeigten Untersuchungen mittels Mikrodialyse, dass diese Punkte eine erhöhte Konzentration an schmerzvermittelten Substanzen besitzen. Darüber hinaus spielen Trigger points im Gegensatz zu Tender points in der Therapie als Ziel lokaler manueller oder medikamentöser Interventionen eine große Rolle in der Beseitigung der Beschwerden.
Abstract
Fibromyalgia syndrome (FMS) and myofascial pain syndrome (MPS) belong to the group of chronic non-inflammatory pain syndromes affecting muscles and tendinous insertions. Important criteria in the diagnosis of both diseases are the presence of “tender points” and “trigger points”. According to ACR criteria FMS is characterized by the presence of tender points whereas trigger points are typically found in MPS.
The main difference is that until now tender points could only be defined in terms of their localization, whereas trigger points can be found upon palpation which may cause a specific referred pain pattern. In addition, analysis of trigger points by microdialysis demonstrated elevated levels of pro-inflammatory substances at these sites. Moreover, local treatment of trigger points either by manipulative therapy or injection appears to be most effective for prompt relief of symptoms.
Literatur
Wolfe F, Smythe HA, Yunus MB et al. (1990) The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160–172
Reynolds MD (1983) The development of the concept of fibrositis. J Hist Med Allied Sci 38: 5–35
Borg-Stein J, Stein J (1996) Trigger points and tender points: one and the same? Does injection treatment help? Rheum Dis Clin North Am 22: 305–322
Croft P, Schollum J, Silman A (1994) Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309: 696–699
Gupta A, McBeth J, Macfarlane GJ et al. (2007) Pressure pain thresholds and tender point counts as predictors of new chronic widespread pain in somatising subjects. Ann Rheum Dis 66: 517–521
Eich W, Hauser W, Friedel E et al. (2008) Definition, classification and diagnosis of fibromyalgia syndrome. Schmerz 22: 255–266
Travell JG (1951) Pain mechanisms in connective tissues. In: Ragan C (ed) Connective tissues: transactions of the second conference. New York, p 86–124
Cummings M, Baldry P (2007) Regional myofascial pain: diagnosis and management. Best Pract Res Clin Rheumatol 21: 367–387
Lavelle ED, Lavelle W, Smith HS (2007) Myofascial trigger points. Med Clin North Am 91: 229–239
De Stefano R, Selvi E, Villanova M et al. (2000) Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome. J Rheumatol 27: 2906–2910
Shah JP, Phillips TM, Danoff JV, Gerber LH (2005) An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 99: 1977–1984
Shah JP (2008) Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis. J Musculoskeletal Pain 16: 17–20
Hubbard DR, Berkoff GM (1993) Myofascial trigger points show spontaneous needle EMG activity. Spine 18: 1803–1807
Simons D (1994) Single-muscle myofascial pain syndromes, 2nd ed. Williams & Wilkins, Baltimore/MD
Wolfe F, Simons DG, Fricton J et al. (1992) The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol 19: 944–951
Gerwin RD, Shannon S, Hong CZ et al. (1997) Interrater reliability in myofascial trigger point examination. Pain 69: 65–73
Myburgh C, Larsen AH, Hartvigsen J (2008) A systematic, critical review of manual palpation for identifying myofascial trigger points: evidence and clinical significance. Arch Phys Med Rehabil 89: 1169–1176
Goldenberg D (1989) Diagnostic and therapeutic challenges of fibromyalgia. Hosp Pract (Off Ed) 24: 39–52
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brezinschek, HP. Mechanismen des Muskelschmerzes. Z. Rheumatol. 67, 653–657 (2008). https://doi.org/10.1007/s00393-008-0353-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-008-0353-y